Monitoring Agency Report for the quarter ended March 31, 2025
ARTEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Artemis Medicare Services has submitted a Monitoring Agency Report to the stock exchanges for the fourth quarter of FY25 (January–March 2025). Monitoring Agency Reports are mandatory SEBI filings required when a company raises capital through routes such as a rights issue, preferential allotment, or qualified institutional placement, where an independent agency must verify how the proceeds are being deployed against the originally disclosed purpose. The report confirms that an independent agency has reviewed the company's use of funds during the quarter. No specific financial numbers, deviations, or observations are mentioned in the headline. The filing is a routine quarterly compliance submission under SEBI's ICDR Regulations.
This is a routine regulatory disclosure and typically has no direct impact on stock price. Shareholders should review the full report to confirm that capital raised earlier has been deployed in line with the stated objectives; any flagged deviation or misuse of funds would be a negative governance signal.